(Q40242958)

18 September 2017

1 reference

title

Clinical pharmacokinetics of atenolol--a review (English)

1 reference

18 September 2017

1 reference

W Kirch

1

1 reference

PubMed ID

6749509

18 September 2017

K G Görg

series ordinal

2

1 reference

18 September 2017

1 January 1982

1 reference

European Journal of Drug Metabolism and Pharmacokinetics

18 September 2017

1 reference

18 September 2017

7

1 reference

18 September 2017

81-91

1 reference

18 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03188723

18 September 2017

0 references

cites work

Relationship between blood level of atenolol and pharmacologic effect

1 reference

https://api.crossref.org/works/10.1007%2FBF03188723

Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188723

The effect of age on plasma levels of propranolol and practolol in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188723

Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188723

Cardiovascular and respiratory effects of cannabis in cat and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188723

The effects of time on the activity of beta-adrenoceptor blocking drugs [proceedings]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188723

Enterohepatic circulation of practolol in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188723

Elimination of guanfacine in patients with normal and impaired renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188723

An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188723

Kinetics and absolute bioavailability of atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188723

Plasma concentrations and the time-course of beta blockade due to propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188723

The gas chromatographic determination of atenolol in biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188723

Pharmacokinetics, pharmacology of atenolol and effect of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188723

Pharmacokinetics of oral propranolol in chronic renal disease

21 January 2018

1 reference

12 December 2020

Atenolol in essential hypertension

1 reference

12 December 2020

Once-daily dosing with Atenolol in patients with mild or moderate hypertension.

1 reference

12 December 2020

Proceedings: Preliminary observations on the human pharmacology of I.C.I. 66082 in normal volunteers

1 reference

12 December 2020

Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males

1 reference

12 December 2020

Protein binding of atenolol and propranolol to human serum albumin and in human plasma [proceedings]

1 reference

12 December 2020

Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker

1 reference

12 December 2020

Problems in assessing beta-adrenoceptor antagonism in man [editorial]

1 reference

12 December 2020

Relationship between renal function and elimination kinetics of pindolol in man

1 reference

12 December 2020

Plasma levels of atenolol after haemodialysis in patients with end stage renal disease

1 reference

12 December 2020

Clinical pharmacokinetics of atenolol

1 reference

12 December 2020

Effect of age on liver function with particular reference to bromsulphalein excretion

1 reference

12 December 2020

Metabolism of Atenolol in Man

1 reference

12 December 2020

New and Expedient Determination of Atenolol in Biological Samples

1 reference

12 December 2020

Nature and incidence of unwanted effects with atenolol

1 reference

12 December 2020

Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol

1 reference

12 December 2020

Atenolol kinetics in renal failure

1 reference

12 December 2020

Comparison Between the Acute Hemodynamic Effects and Brain Penetration of Atenolol and Metoprolol

1 reference

12 December 2020

Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension

1 reference

12 December 2020

Studies on the pharmacokinetics and pharmacodynamics of atenolol in man

1 reference

12 December 2020

Single intravenous dose kinetics accumulation of atenolol in patients with impaired renal function and on hemodialysis

1 reference

12 December 2020

Once-daily deta-blockers and blood-pressure response to exercise

1 reference

12 December 2020

Individualization of propranolol therapy.

1 reference

12 December 2020

Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.

1 reference

12 December 2020

Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations

1 reference

12 December 2020

The influence of renal function on plasma levels, urinary excretion, metabolism, and antihypertensive effect of guanethidine (ismelin) in man

1 reference

12 December 2020

The clinical importance of cardioselectivity and lipophilicity in beta blockers.

1 reference

12 December 2020

On the mechanism of intestinal absorption of drugs

1 reference

12 December 2020

New Method for Calculating the Intrinsic Absorption Rate of Drugs

1 reference

12 December 2020

Pharmacokinetics of atenolol in relation to renal function

1 reference

12 December 2020

GLC Determination of Atenolol and β-Blocking Agents in Biological Fluids

1 reference

12 December 2020

Pharmacokinetics of atenolol in patients with renal impairment

1 reference

12 December 2020

Food-induced reduction in bioavailability of atenolol

1 reference

12 December 2020

Rapid determination of atenolol in human plasma and urine by high-pressure liquid chromatography

1 reference

12 December 2020

Fluorimetric determination of atenolol in plasma and urine by direct evaluation of thin-layer chromatograms

1 reference

12 December 2020

Disposition and Metabolism of Atenolol in Animals

1 reference

12 December 2020

Increased Plasma Protein Binding of Propranolol and Chlorpromazine Mediated by Disease-Induced Elevations of Plasma α1Acid Glycoprotein

1 reference

12 December 2020

Interaction of cimetidine with metoprolol, propranolol, or atenolol

1 reference

12 December 2020

Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man

1 reference

12 December 2020

Response to atenolol in arterial hypertension in relation to renal function, pharmacokinetics and renin activity

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03188723

1 reference

PubMed ID

6749509

Dimensions Publication ID

18 September 2017

0 references

1 reference

PubMed ID

6749509